Brief: EQL Pharma Q3 EBITDA up 120 pct YoY

EQL Pharma AB

24/10/2017 09:32

Oct 24 (Reuters) - EQL PHARMA AB  EQL.ST : 
    * EBITDA FOR Q3 AMOUNTED TO SEK 0.9 (0.4) MILLION, AN 
INCREASE OF 120% 
 
Source text for Eikon:  ID:nWkrLqzB4  
Further company coverage:  EQL.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))